Laura Salgado Boquete-rekin lankidetzan egindako argitalpenak (2)

2023

  1. Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 12, pp. 2517-2525

2022

  1. Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study

    Dermatologic Therapy